SPDR S&P Biotech ETF
523 hedge funds and large institutions have $9.36B invested in SPDR S&P Biotech ETF in 2020 Q2 according to their latest regulatory filings, with 127 funds opening new positions, 186 increasing their positions, 126 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
14% more funds holding
Funds holding: 457 → 523 (+66)
41.76% less ownership
Funds ownership: 211.36% → 169.6% (-42%)
64% less call options, than puts
Call options by funds: $1.13B | Put options by funds: $3.12B
Holders
523
Holding in Top 10
17
Calls
$1.13B
Puts
$3.12B
Top Buyers
| 1 | +$123M | |
| 2 | +$80.8M | |
| 3 | +$34.4M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$28.1M |
| 5 |
WKKFT
W.K. Kellogg Foundation Trust
Battle Creek,
Michigan
|
+$28.1M |
Top Sellers
| 1 | -$284M | |
| 2 | -$226M | |
| 3 | -$215M | |
| 4 |
Morgan Stanley
New York
|
-$163M |
| 5 |
N
Natixis
Paris,
France
|
-$155M |